Perugia
Italy
76
2025-12-11
The entities that hold a legal rights for patent applications filed by inventor Pellicciari Roberto:
Roberto Pellicciari from Perugia, IT has applied for patents for these inventions. The list has both pending applications and granted patents:
FARNESOID X RECEPTOR MODULATORS
#2 | 2024-12-05FARNESOID X RECEPTOR MODULATORS
#3 | 2024-11-28HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATING ACUTE INFLAMMATION
#4 | 2023-12-28PYRIMIDINONE COMPOUNDS FOR TREATING ACUTE INFLAMMATION
#5 | 2023-11-30Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
#6 | 2023-07-27FARNESOID X RECEPTOR MODULATORS
#7 | 2023-02-16COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF TUMORS
#8 | 2022-12-01TGR5 modulators and methods of use thereof
#9 | 2022-11-10INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
#10 | 2022-07-07HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
#11 | 2022-04-28METHODS AND INTERMEDIATES FOR THE PREPARATION OF BILE ACID DERIVATIVES
#12 | 2021-12-09INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
#13 | 2021-11-11TREATMENT OF FIBROSIS USING FXR LIGANDS
#14 | 2021-10-21HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
#15 | 2021-09-02Farnesoid X receptor modulators
#16 | 2021-09-02TGR5 MODULATORS AND METHODS OF USE THEREOF
#17 | 2021-07-29INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
#18 | 2021-07-29FARNESOID X RECEPTOR MODULATORS
#19 | 2021-04-29TGR5 modulators and methods of use thereof
#20 | 2021-04-083-desoxy derivative and pharmaceutical compositions thereof
#21 | 2020-12-24TREATMENT OF FIBROSIS USING FXR LIGANDS
#22 | 2020-09-24Farnesoid x receptor modulators
#23 | 2020-07-02Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
#24 | 2020-06-25Treatment of fibrosis using FXR ligands
#25 | 2019-10-03STEROIDS AS AGONISTS FOR FXR
#26 | 2019-09-19TGR5 modulators and methods of use thereof
#27 | 2019-07-11Farnesoid X receptor modulators
#28 | 2019-01-10Methods for preparation of bile acids and derivatives thereof
#29 | 2019-01-033-DESOXY DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS THEREOF
#30 | 2018-12-27Methods and intermediates for the preparation of bile acid derivatives
#31 | 2018-05-17INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE
#32 | 2018-03-22Process for preparing bile acid derivatives
#33 | 2018-01-18TGR5 Modulators and Methods of Use Thereof
#34 | 2017-12-21Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
#35 | 2017-10-26Steroids as agonists for FXR
#36 | 2017-09-143-desoxy derivative and pharmaceutical compositions thereof
#37 | 2017-08-03FARNESOID X RECEPTOR MODULATORS
#38 | 2017-06-15Treatment of fibrosis using FXR ligands
#39 | 2017-04-13Farnesoid X receptor modulators
#40 | 2016-06-02Steroids as agonists for FXR
#41 | 2016-04-07TGR5 Modulators and Methods of Use Thereof
#42 | 2016-03-03Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase
#43 | 2016-02-25TGR5 modulators and methods of use thereof
#44 | 2015-12-17Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
#45 | 2015-10-15Process for preparing bile acid derivatives
#46 | 2015-06-18Steroids as Agonists for FXR
#47 | 2015-05-14Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
#48 | 2014-12-18Farnesoid X receptor modulators
#49 | 2014-04-17Thienyl- and furanyl-isoquinolinones and methods for using them
#50 | 2014-04-10TGR5 modulators and methods of use thereof
#51 | 2014-04-03TGR5 modulators and methods of use thereof
#52 | 2014-02-27Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
#53 | 2014-01-23Steroids as agonists for FXR
#54 | 2013-03-07Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
#55 | 2012-11-08Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
#56 | 2012-05-10TGR5 modulators and methods of use thereof
#57 | 2012-03-01Steroids as agonists for FXR
#58 | 2011-10-27TGR5 modulators and methods of use thereof
#59 | 2011-09-29THIENO[2,3-C] ISOQUINOLINES FOR USE AS INHIBITORS OF PARP
#60 | 2011-07-14TGR5 modulators and methods of use thereof
#61 | 2011-06-16Inhibitors of Kynurenine Aminotransferase and Uses Therefor
#62 | 2011-01-0623-substituted bile acids as TGR5 modulators and methods of use thereof
#63 | 2010-06-17TGR5 modulators and methods of use thereof
#64 | 2010-03-11Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
#65 | 2010-01-28Steroids as agonists for FXR
#66 | 2009-12-31Thienyl-and furanyl-isoquinolinones and methods for using them
#67 | 2009-12-24Thiazolyl-and oxazolyl-isoquinolinones and methods for using them
#68 | 2008-09-04Process for preparing 3a(β)-7a(β)-dihydroxy-6a(β)-alkyl-5β-cholanic acid
#69 | 2008-07-31Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
#70 | 2008-06-05Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
#71 | 2008-02-14Steroid agonist for FXR
#72 | 2007-06-21Steroids as agonists for FXR
#73 | 2006-11-09Method of reducing drug-induced adverse side effects in a patient
#74 | 2006-05-04Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
#75 | 2006-03-30Treatment of fibrosis using FXR ligands
#76 | 2005-04-14Steroids as agonists for FXR
128980 ⎘